 |
 Video: What is a Stock Split?
|
|
|
| Emergent BioSolutions is a life sciences company focused on providing preparedness and response solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The types of PHTs Co. is addressing are focused on the following five categories: chemical, biological, radiological, nuclear and explosives; emerging infectious diseases; travel health; public health crises (such as the opioid crisis and the COVID-19 pandemic); and acute, emergency, and community care. Co. operates under three separate business lines: the Government - Medical Countermeasures; the Commercial; and the Services - contract development and manufacturing. According to our Emergent BioSolutions stock split history records, Emergent BioSolutions has had 0 splits. | |
|
Emergent BioSolutions (EBS) has 0 splits in our Emergent BioSolutions stock split history database.
Looking at the Emergent BioSolutions stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Emergent BioSolutions shares, starting with a $10,000 purchase of EBS, presented on a split-history-adjusted basis factoring in the complete Emergent BioSolutions stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$26.78 |
|
| End price/share: |
$1.86 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-93.05% |
|
| Average Annual Total Return: |
-23.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$694.18 |
|
| Years: |
10.00 |
|
|
|
|
|
